Skip to main content

Advertisement

Table 2 Cases where multistep strategy 2.2 is clinically superior to single-step strategy 2.2 and vice versa

From: Long range personalized cancer treatment strategies incorporating evolutionary dynamics

Number of drugs Multistep > Single-step Single-step > Multistep
2 6199 (99.8 %) 13 (0.2 %)
3 18909 (99.99 %) 2 (0.01 %)